These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16392807)

  • 21. Platinum(IV) analogues of AMD473 (cis-[PtCl2(NH3)(2-picoline)]): preparative, structural, and electrochemical studies.
    Battle AR; Choi R; Hibbs DE; Hambley TW
    Inorg Chem; 2006 Aug; 45(16):6317-22. PubMed ID: 16878941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platinum (II) complexes with stereochemically-defined thiepane dioxide diamine ligands as anticancer drugs.
    Cerè V; Grossi L; Munari D; Pollicino S; Martelli L; Martelli M
    Anticancer Res; 2006; 26(3A):1815-9. PubMed ID: 16827112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro biochemical and pharmacological evaluation of a novel cytotoxic dinuclear platinum(II) complex with 3-amino-5-methyl-5-phenylhydantoin.
    Momekov GTs; Ugrinova I; Pasheva EA; Bakalova AG; Varbanov HP; Ferdinandov DV; Ivanov DS; Konstantinov SM
    Ann N Y Acad Sci; 2009 Aug; 1171():649-58. PubMed ID: 19723116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, characterization and cytotoxicity of ammine/ethylamine platinum(II) complexes with carboxylates.
    Zhang J; Li Y; Sun J
    Eur J Med Chem; 2009 Jun; 44(6):2758-62. PubMed ID: 19056150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Palladium(II) and platinum(II) organometallic complexes with the model nucleobase anions of thymine, uracil, and cytosine: antitumor activity and interactions with DNA of the platinum compounds.
    Ruiz J; Lorenzo J; Sanglas L; Cutillas N; Vicente C; Villa MD; Avilés FX; López G; Moreno V; Pérez J; Bautista D
    Inorg Chem; 2006 Aug; 45(16):6347-60. PubMed ID: 16878945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cationic nonsymmetric transplatinum complexes with piperidinopiperidine ligands. Preparation, characterization, in vitro cytotoxicity, in vivo toxicity, and anticancer efficacy studies.
    Najajreh Y; Khazanov E; Jawbry S; Ardeli-Tzaraf Y; Perez JM; Kasparkova J; Brabec V; Barenholz Y; Gibson D
    J Med Chem; 2006 Jul; 49(15):4665-73. PubMed ID: 16854072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and characterization of novel trans-[PtCl(2)(amine)(isopropylamine)] compounds: cytotoxic activity and apoptosis induction in ras-transformed cells.
    Montero EI; Díaz S; González-Vadillo AM; Pérez JM; Alonso C; Navarro-Ranninger C
    J Med Chem; 1999 Oct; 42(20):4264-8. PubMed ID: 10514297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aryl, methyl-diplatinum complexes each with a metal-metal donor-acceptor bond and bridging 2-diphenylphosphinopyridine (PN) ligands: general synthetic approach and mechanism of isomerization.
    Shafaatian B; Akbari A; Nabavizadeh SM; Heinemann FW; Rashidi M
    Dalton Trans; 2007 Nov; (41):4715-25. PubMed ID: 17940654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, characterization, interaction with DNA and cytotoxicity in vitro of dinuclear Pd(II) and Pt(II) complexes dibridged by 2,2'-azanediyldibenzoic acid.
    Gao E; Zhu M; Yin H; Liu L; Wu Q; Sun Y
    J Inorg Biochem; 2008 Oct; 102(10):1958-64. PubMed ID: 18760841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, characterization and cytotoxic activity of substituted benzyl iminoether Pt(II) complexes of the type cis- and trans-[PtCl2{E-N(H)=C(OMe)CH2-C6H4-p-R}2] (R=Me, OMe, F). X-ray structure of trans-[PtCl2{E-N(H)=C(OMe)CH2-C6H4-p-F}2].
    Mazzega Sbovata S; Bettio F; Marzano C; Tassan A; Mozzon M; Bertani R; Benetollo F; Michelin RA
    J Inorg Biochem; 2008 Apr; 102(4):882-91. PubMed ID: 18267343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mono- and polynuclear [alkylamine]platinum(II) complexes of [1,2-bis(4-fluorophenyl)ethylenediamine]platinum(II): synthesis and investigations on cytotoxicity, cellular distribution, and DNA and protein binding.
    Kapp T; Dullin A; Gust R
    J Med Chem; 2006 Feb; 49(3):1182-90. PubMed ID: 16451082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
    Liu W; Chen X; Xie M; Lou L; Ye Q; Yu Y; Hou S
    J Inorg Biochem; 2008 Oct; 102(10):1942-6. PubMed ID: 18707762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, X-ray crystallographic, and NMR characterizations of platinum(II) and platinum(IV) pyrophosphato complexes.
    Mishur RJ; Zheng C; Gilbert TM; Bose RN
    Inorg Chem; 2008 Sep; 47(18):7972-82. PubMed ID: 18693681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.
    Ruiz J; Villa MD; Cutillas N; López G; de Haro C; Bautista D; Moreno V; Valencia L
    Inorg Chem; 2008 Jun; 47(11):4490-505. PubMed ID: 18447329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenanthroline derivatives with improved selectivity as DNA-targeting anticancer or antimicrobial drugs.
    Roy S; Hagen KD; Maheswari PU; Lutz M; Spek AL; Reedijk J; van Wezel GP
    ChemMedChem; 2008 Sep; 3(9):1427-34. PubMed ID: 18537202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, cytotoxic effect, and structure-activity relationship of Pd(II) complexes with coumarin derivatives.
    Budzisz E; Małecka M; Lorenz IP; Mayer P; Kwiecień RA; Paneth P; Krajewska U; Rózalski M
    Inorg Chem; 2006 Nov; 45(24):9688-95. PubMed ID: 17112264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines.
    Coley HM; Sarju J; Wagner G
    J Med Chem; 2008 Jan; 51(1):135-41. PubMed ID: 18072719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation of platinum(IV) complexes with dipeptide and diimine. X-ray crystal structure and 195Pt NMR spectra.
    Watabe M; Fukuda H; Kitsukawa K; Nakajima H; Yukawa Y; Igarashi S; Fujii Y; Takayama T
    J Inorg Biochem; 2006 Oct; 100(10):1653-9. PubMed ID: 16857262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, characterization, and in vitro cytotoxicity of some gold(I) and trans platinum(II) thionate complexes containing water-soluble PTA and DAPTA ligands. X-ray crystal structures of [Au(SC4H3N2)(PTA)], trans-[Pt(SC4H3N2)2(PTA)2], trans-[Pt(SC5H4N)2(PTA)2], and trans-[Pt(SC5H4N)2(DAPTA)2].
    Miranda S; Vergara E; Mohr F; de Vos D; Cerrada E; Mendía A; Laguna M
    Inorg Chem; 2008 Jul; 47(13):5641-8. PubMed ID: 18447334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells.
    Garmann D; Warnecke A; Kalayda GV; Kratz F; Jaehde U
    J Control Release; 2008 Oct; 131(2):100-6. PubMed ID: 18691617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.